WEREWOLF THERAPEUTICS, INC. Operating Lease Liability
WEREWOLF THERAPEUTICS, INC. (HOWL) had Operating Lease Liability of $2.50 million as of 2026-05-07, per its S-4 filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-09-22
- 2026-05-07: Operating Lease, Liability $2.50M.
- 2025-12-31: Operating Lease, Liability $9.44M.
- 2024-12-31: Operating Lease, Liability $10.99M.
- 2023-12-31: Operating Lease, Liability $12.60M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-05-07 | $2.50M S-4 · filed 2026-09-22 |
| 2025-12-31 | $9.44M S-4 · filed 2026-09-22 |
| 2024-12-31 | $10.99M 10-K · filed 2025-03-11 |
| 2023-12-31 | $12.60M 10-K · filed 2024-03-07 |
| 2022-12-31 | $14.68M 10-K · filed 2023-03-23 |
| 2022-09-30 | $15.16M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $15.55M 10-Q · filed 2022-08-11 |
| 2021-12-31 | $15.66M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |